Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Sibilia

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2011
hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancerMichael Wittinger, Petr Vanhara, Ahmed El-Gazzar, et al.
Immunity|January 22, 2013
Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptorDietmar M W Zaiss, Jorg van Loosdregt, Andrea Gorlani, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 13, 2026
Improved Systemic Immunochemotherapy Employing an Oxaliplatin-TLR7/8 Agonist Prodrug StrategyMichael Gutmann, Martijn Dijkstra, Philipp Salomon, et al.
Journal of Personalized Medicine|October 29, 2020
Targeted Therapy Recommendations for Therapy Refractory Solid Tumors-Data from the Real-World Precision Medicine Platform MONDTIHossein Taghizadeh, Matthias Unseld, Martina Spalt, et al.
Immunity|October 19, 2017
Epidermal Growth Factor Receptor Expression Licenses Type-2 Helper T Cells to Function in a T Cell Receptor-Independent FashionCarlos M Minutti, Sebastian Drube, Natalie Blair, et al.
ESMO Open|August 20, 2019
Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTIMarkus Kieler, Matthias Unseld, Daniela Bianconi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2018
BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 AntibodyMartina Sanlorenzo, Igor Vujic, Arianna Floris, et al.
EMBO Reports|September 11, 2023
Defects in microvillus crosslinking sensitize to colitis and inflammatory bowel diseaseBernadette Mödl, Monira Awad, Daniela Zwolanek, et al.
Science Signaling|December 13, 2022
Stress signaling boosts interferon-induced gene transcription in macrophagesLaura Boccuni, Elke Podgorschek, Moritz Schmiedeberg, et al.
Basic Research in Cardiology|September 4, 2020
Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertensionMax-Paul Winter, Smriti Sharma, Johanna Altmann, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2011
hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancerMichael Wittinger, Petr Vanhara, Ahmed El-Gazzar, et al.
Immunity|January 22, 2013
Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptorDietmar M W Zaiss, Jorg van Loosdregt, Andrea Gorlani, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 13, 2026
Improved Systemic Immunochemotherapy Employing an Oxaliplatin-TLR7/8 Agonist Prodrug StrategyMichael Gutmann, Martijn Dijkstra, Philipp Salomon, et al.
Journal of Personalized Medicine|October 29, 2020
Targeted Therapy Recommendations for Therapy Refractory Solid Tumors-Data from the Real-World Precision Medicine Platform MONDTIHossein Taghizadeh, Matthias Unseld, Martina Spalt, et al.
Immunity|October 19, 2017
Epidermal Growth Factor Receptor Expression Licenses Type-2 Helper T Cells to Function in a T Cell Receptor-Independent FashionCarlos M Minutti, Sebastian Drube, Natalie Blair, et al.
ESMO Open|August 20, 2019
Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTIMarkus Kieler, Matthias Unseld, Daniela Bianconi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2018
BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 AntibodyMartina Sanlorenzo, Igor Vujic, Arianna Floris, et al.
EMBO Reports|September 11, 2023
Defects in microvillus crosslinking sensitize to colitis and inflammatory bowel diseaseBernadette Mödl, Monira Awad, Daniela Zwolanek, et al.
Science Signaling|December 13, 2022
Stress signaling boosts interferon-induced gene transcription in macrophagesLaura Boccuni, Elke Podgorschek, Moritz Schmiedeberg, et al.
Basic Research in Cardiology|September 4, 2020
Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertensionMax-Paul Winter, Smriti Sharma, Johanna Altmann, et al.
Pageof 12